Weight loss injections and suicide: Investigating the connection
The Pharmacovigilance Risk Assessment Committee (PRAS) of the European Medicines Authority (EMA) and the FDA have initiated investigations into the potential connection between weight loss injections and suicidal thoughts. The EMA is demanding research information from manufacturers of diabetes drugs, which have gained popularity for weight loss, regarding the risk of suicidal thoughts among users […]
Continue Reading